RAB11B and breast carcinoma: Examination of breast cancer cells in culture reveals that knocking down Rab11b slightly decreases overall expression of integrin β1, but leads to dramatic loss of cell-surface integrin β1 (Fig. 4k), suggesting a loss of localization.